Vetropack Holding Valuation
Is VETNZ undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
6/6Valuation Score 6/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of VETNZ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: VETNZ (CHF31.95) is trading below our estimate of fair value (CHF117.15)
Significantly Below Fair Value: VETNZ is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for VETNZ?
Other financial metrics that can be useful for relative valuation.
What is VETNZ's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | CHF 627.43m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 0.9x |
Enterprise Value/EBITDA | 4.8x |
PEG Ratio | 0.8x |
Price to Earnings Ratio vs Peers
How does VETNZ's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 26.4x | ||
IBST Ibstock | 32.2x | 28.8% | UK£679.1m |
PAF Pan African Resources | 9.4x | 36.7% | UK£551.0m |
MSLH Marshalls | 44.5x | 28.5% | UK£827.6m |
ATYM Atalaya Mining | 19.3x | 34.2% | UK£487.0m |
VETNZ Vetropack Holding | 9.9x | 12.0% | CHF 627.4m |
Price-To-Earnings vs Peers: VETNZ is good value based on its Price-To-Earnings Ratio (9.9x) compared to the peer average (26.4x).
Price to Earnings Ratio vs Industry
How does VETNZ's PE Ratio compare vs other companies in the European Packaging Industry?
Price-To-Earnings vs Industry: VETNZ is good value based on its Price-To-Earnings Ratio (9.9x) compared to the European Packaging industry average (14.6x).
Price to Earnings Ratio vs Fair Ratio
What is VETNZ's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 9.9x |
Fair PE Ratio | 14.4x |
Price-To-Earnings vs Fair Ratio: VETNZ is good value based on its Price-To-Earnings Ratio (9.9x) compared to the estimated Fair Price-To-Earnings Ratio (14.4x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | CHF 31.95 | CHF 45.33 +41.9% | 9.1% | CHF 50.00 | CHF 40.00 | n/a | 3 |
Jul ’25 | CHF 32.85 | CHF 45.33 +38.0% | 9.1% | CHF 50.00 | CHF 40.00 | n/a | 3 |
Jun ’25 | CHF 31.60 | CHF 45.33 +43.5% | 9.1% | CHF 50.00 | CHF 40.00 | n/a | 3 |
May ’25 | CHF 31.33 | CHF 45.33 +44.7% | 9.1% | CHF 50.00 | CHF 40.00 | n/a | 3 |
Apr ’25 | CHF 32.80 | CHF 45.33 +38.2% | 9.1% | CHF 50.00 | CHF 40.00 | n/a | 3 |
Mar ’25 | CHF 36.35 | CHF 52.00 +43.1% | 9.8% | CHF 60.00 | CHF 46.00 | n/a | 4 |
Feb ’25 | CHF 36.80 | CHF 54.75 +48.8% | 7.2% | CHF 60.00 | CHF 50.00 | n/a | 4 |
Jan ’25 | CHF 39.05 | CHF 54.75 +40.2% | 7.2% | CHF 60.00 | CHF 50.00 | n/a | 4 |
Dec ’24 | CHF 35.95 | CHF 54.75 +52.3% | 7.2% | CHF 60.00 | CHF 50.00 | n/a | 4 |
Nov ’24 | CHF 35.95 | CHF 54.75 +52.3% | 7.2% | CHF 60.00 | CHF 50.00 | n/a | 4 |
Oct ’24 | CHF 40.30 | CHF 54.75 +35.9% | 7.2% | CHF 60.00 | CHF 50.00 | n/a | 4 |
Sep ’24 | CHF 47.05 | CHF 54.75 +16.4% | 7.2% | CHF 60.00 | CHF 50.00 | n/a | 4 |
Aug ’24 | CHF 43.65 | CHF 54.75 +25.4% | 7.2% | CHF 60.00 | CHF 50.00 | CHF 32.85 | 4 |
Jul ’24 | CHF 41.45 | CHF 54.75 +32.1% | 7.2% | CHF 60.00 | CHF 50.00 | CHF 32.85 | 4 |
Jun ’24 | CHF 41.25 | CHF 54.50 +32.1% | 7.0% | CHF 60.00 | CHF 50.00 | CHF 31.60 | 4 |
May ’24 | CHF 46.20 | CHF 54.50 +18.0% | 7.0% | CHF 60.00 | CHF 50.00 | CHF 31.33 | 4 |
Apr ’24 | CHF 46.30 | CHF 50.00 +8.0% | 19.8% | CHF 60.00 | CHF 34.00 | CHF 32.80 | 4 |
Mar ’24 | CHF 44.10 | CHF 50.00 +13.4% | 19.8% | CHF 60.00 | CHF 34.00 | CHF 36.35 | 4 |
Feb ’24 | CHF 42.50 | CHF 50.00 +17.6% | 19.8% | CHF 60.00 | CHF 34.00 | CHF 36.80 | 4 |
Jan ’24 | CHF 36.20 | CHF 48.50 +34.0% | 19.2% | CHF 60.00 | CHF 34.00 | CHF 39.05 | 4 |
Dec ’23 | CHF 34.05 | CHF 48.50 +42.4% | 19.2% | CHF 60.00 | CHF 34.00 | CHF 35.95 | 4 |
Nov ’23 | CHF 31.98 | CHF 50.25 +57.2% | 13.4% | CHF 60.00 | CHF 41.00 | CHF 35.95 | 4 |
Oct ’23 | CHF 29.10 | CHF 50.25 +72.7% | 13.4% | CHF 60.00 | CHF 41.00 | CHF 40.30 | 4 |
Sep ’23 | CHF 33.50 | CHF 50.25 +50.0% | 13.4% | CHF 60.00 | CHF 41.00 | CHF 47.05 | 4 |
Aug ’23 | CHF 37.50 | CHF 56.25 +50.0% | 21.8% | CHF 74.00 | CHF 41.00 | CHF 43.65 | 4 |
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.